Andrew Leask (A Leask)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Cancer research communications

Journal of dental research

Expert opinion on investigational drugs

Journal of cell communication and signaling

University of Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Chicago

United States

PHD :: Molecular Genetics and Cell Biology

University of British Columbia

Canada

BSC :: Biology

Publications

Andrew Leask, Asmaa Fadl, Angha Naik
A modest proposal: targeting αv integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis. Expert opinion on investigational drugs 33 (3) (2024)
Antonio Tejera-Muñoz, Marcelino Cortés García, Alianet Rodriguez-Rodriguez, Lucia Tejedor-Santamaria, Vanessa Marchant, Sandra Rayego-Mateos, Maria José Gimeno-Longas, Andrew Leask, Tri Q Nguyen, María Martín, José Tuñón Fernández, Isabel Rodríguez, Marta Ruiz-Ortega, Raul R Rodrigues-Díez
Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice. International journal of molecular sciences 25 (17) (2024)
James Hutchenreuther, John Nguyen, Katherine Quesnel, Krista Marie Vincent, Louis Petitjean, Sophia Bourgeois, Mark Boyd, George Bou-Gharios, Lynne-Marie Postovit, Andrew Leask
Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis. Cancer research communications 4 (2) (2024)
Andrew Leask, Asmaa Fadl, Angha Naik
A modest proposal: targeting αv integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis. Expert opinion on investigational drugs (2024)
James Hutchenreuther, John Nguyen, Katherine Quesnel, Krista Marie Vincent, Louis Petitjean, Sophia Bourgeois, Mark Boyd, George Bou-Gharios, Lynne-Marie Postovit, Andrew Leask
Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis. Cancer research communications 4 (2) (2024)
M Sharma, A Fadl, Andrew Leask
Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis. Journal of dental research 103 (7) (2024)
James Hutchenreuther, John Nguyen, Katherine Quesnel, Krista Marie Vincent, Louis Petitjean, Sophia Bourgeois, Mark Boyd, George Bou-Gharios, Lynne-Marie Postovit, Andrew Leask
Cancer-associated fibroblast-specific expression of the matricellular protein CCN1 coordinates neovascularization and stroma deposition in melanoma metastasis. Cancer research communications (2024)
M Sharma, A Fadl, Andrew Leask
Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis. Journal of dental research 103 (7) (2024)
Andrew Leask, Asmaa Fadl, Angha Naik
A modest proposal: targeting αv integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis. Expert opinion on investigational drugs 33 (3) (2024)
Andrew Leask, Asmaa Fadl, Angha Naik
A modest proposal: targeting αv integrin-mediated activation of latent TGFbeta as a novel therapeutic approach to treat scleroderma fibrosis. Expert opinion on investigational drugs (2024)
M Sharma, A Fadl, Andrew Leask
Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis. Journal of dental research 103 (7) (2024)
James Hutchenreuther, John Nguyen, Katherine Quesnel, Krista Marie Vincent, Louis Petitjean, Sophia Bourgeois, Mark Boyd, George Bou-Gharios, Lynne-Marie Postovit, Andrew Leask
Cancer-associated Fibroblast-specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis. Cancer research communications 4 (2) (2024)
M Sharma, A Fadl, Andrew Leask
Orofacial Complications of the Connective Tissue Disease Systemic Sclerosis. Journal of dental research (2024)
Pratyusha Chitturi, Shiwen Xu, Bahja Ahmed Abdi, John Nguyen, David E Carter, Sarthak Sinha, Rohit Arora, Jeff Biernaskie, Richard J Stratton, Andrew Leask
Tripterygium wilfordii derivative celastrol, a YAP inhibitor, has antifibrotic effects in systemic sclerosis. Annals of the rheumatic diseases (2023)
Andrew Leask, Angha Naik, Richard J Stratton
Back to the future: targeting the extracellular matrix to treat systemic sclerosis. Nature reviews. Rheumatology (2023)
Asmaa Fadl, Andrew Leask
Hiding in Plain Sight: Human Gingival Fibroblasts as an Essential, Yet Overlooked, Tool in Regenerative Medicine. Cells 12 (16) (2023)
Xu Shi-Wen, Michael Racanelli, Aaisham Ali, Amara Simon, Katherine Quesnel, Richard J Stratton, Andrew Leask
Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts. Journal of cell communication and signaling 15 (1) (2021)
Andrew Leask
The hard problem: Mechanotransduction perpetuates the myofibroblast phenotype in scleroderma fibrosis. Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 29 (4) (2021)
Alexander Peidl, Bernard Perbal, Andrew Leask
Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts. PloS one 14 (6) (2019)
Andrew Leask
Do drugs that target mTOR generate CCN2-mediated fibrogenic side effects? Journal of cell communication and signaling 13 (3) (2019)
Ebru Ercan, Juliette M Han, Alessia Di Nardo, Kellen Winden, Min-Joon Han, Leonie Hoyo, Afshin Saffari, Andrew Leask, Daniel H Geschwind, Mustafa Sahin
Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. The Journal of experimental medicine 214 (3) (2017)
Hannah Murphy-Marshman, Katherine Quensel, Xu Shi-Wen, Rebecca Barnfield, Jacalyn Kelly, Alex Peidl, Richard J Stratton, Andrew Leask
Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblasts. PloS one 12 (10) (2017)

Andrew Leask.css-eqlu8i{font-size:small;padding-left:4px;} (A Leask)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew Leask (A Leask)